Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial
暂无分享，去创建一个
S. Vermeire | T. Hibi | G. Rogler | F. Seibold | R. Fogel | Mamoru Watanabe | H. J. Kim | L. Peyrin-Biroulet | W. Sandborn | B. Feagan | E. Loftus | S. Danese | R. Mehta | R. Filip | U. Seidler | S. Nijhawan | J. McNally | C. Hsueh | R. Kempiński | C. Yun | I. Beales | T. Ritter | R. Besuyen | Chantal Tasset | S. Schreiber | Sally Zhao | I. Hospodarskyy | Xiaopeng Liu | Hyo Jong Kim